Versant Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.87K Sell
134
-179
-57% -$2.5K ﹤0.01% 2394
2025
Q1
$4.22K Buy
313
+231
+282% +$3.11K ﹤0.01% 2083
2024
Q4
$1.57K Buy
+82
New +$1.57K ﹤0.01% 2106